ADARx Pharmaceuticals, Inc. Common Stock (ADRX) — Financial Flexibility Index
ADARx Pharmaceuticals, Inc. Common Stock (ADRX) has a Financial Flexibility Index of -0.04x as of June 2026. Free cash flow of $-26.82 Million (operating CF $-27.19 Million minus capex $367.00K) represents 0% of total liabilities ($707.38 Million). Explore reinvestment intensity of ADARx Pharmaceuticals, Inc. Common Stock to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ADARx Pharmaceuticals, Inc. Common Stock Financial Flexibility Index (2024–2025)
Historical Financial Flexibility Index trend for ADARx Pharmaceuticals, Inc. Common Stock across 2 annual periods. Check ADARx Pharmaceuticals, Inc. Common Stock investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Financial Flexibility Index for ADARx Pharmaceuticals, Inc. Common Stock (2024–2025)
Year-by-year free cash flow to debt coverage for ADARx Pharmaceuticals, Inc. Common Stock. For the full cash flow conversion analysis, see ADRX cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.37x | $265.22 Million | $262.29 Million | $709.91 Million | ▲ +387.8% |
| 2024 | -0.13x | $-48.11 Million | $-48.56 Million | $370.60 Million | — |